These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1125783)

  • 21. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.
    Maas JW
    Arch Gen Psychiatry; 1975 Nov; 32(11):1357-61. PubMed ID: 1200759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW
    Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536
    [No Abstract]   [Full Text] [Related]  

  • 24. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 25. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemistry of the affective disorders.
    Maas JW
    Hosp Pract; 1979 May; 14(5):113-20. PubMed ID: 225259
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoamine metabolites as indicators of the effect of centrally acting drugs on monoamine release in rat brain.
    Karasawa T; Furukawa K; Ochi Y; Shimizu M
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):261-73. PubMed ID: 646524
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the potential antidepressant AHR-1118 on amine uptake and on plasma 3-methoxy-4-hydroxyphenylglycol in manic-depressive illness [proceedings].
    Halaris AE; DeMet EM
    Psychopharmacol Bull; 1979 Apr; 15(2):95-7. PubMed ID: 432388
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of an improved cerebroventricular perfusion technique in the rabbit: effects of pentobarbital or haloperidol on monoamine metabolites and proteins in the perfusate.
    Barkai A; Budek M; Brown DL; Fieve RR
    Neuropharmacology; 1978 Jun; 17(6):409-14. PubMed ID: 673155
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa.
    Davis BA; Kennedy SH; Durden DA; D'Souza J; Goldbloom DS; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):747-63. PubMed ID: 7504824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 32. Biogenic amine status in acute fulminant hepatocellular failure in children.
    Krishnamoorthy MS; Sundaravalli N; Soundar S; Karthikeyan S
    Indian J Physiol Pharmacol; 1989; 33(1):15-20. PubMed ID: 2472360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.
    Kennedy SH; Davis BA; Brown GM; Ford CG; d'Souza J
    Neurochem Res; 1993 Dec; 18(12):1281-5. PubMed ID: 7505890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some aspects of basic psychopharmacology: the trace amines.
    Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):563-70. PubMed ID: 6298892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-treatment interaction between amantadine and chlorpromazine in the mouse.
    Messiha FS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(3):323-6. PubMed ID: 1723037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of methiothepin on cerebral monoamine neurons.
    Lloyd KG; Bartholini G
    Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
    [No Abstract]   [Full Text] [Related]  

  • 37. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 38. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduced central serotonergic activity in mania: implications for the relationship between depression and mania.
    Mendels J; Frazer A
    Br J Psychiatry; 1975 Mar; 126():241-8. PubMed ID: 1125505
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.